326 related articles for article (PubMed ID: 17921085)
21. PET in face and neck tumours.
Rankin SC
Cancer Imaging; 2006 Oct; 6(Spec No A):S89-95. PubMed ID: 17114083
[TBL] [Abstract][Full Text] [Related]
22. Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen.
Metser U; You J; McSweeney S; Freeman M; Hendler A
AJR Am J Roentgenol; 2010 Mar; 194(3):766-71. PubMed ID: 20173157
[TBL] [Abstract][Full Text] [Related]
23. Improvement in the detection of locoregional recurrence in head and neck malignancies: F-18 fluorodeoxyglucose-positron emission tomography/computed tomography compared to high-resolution contrast-enhanced computed tomography and endoscopic examination.
Rangaswamy B; Fardanesh MR; Genden EM; Park EE; Fatterpekar G; Patel Z; Kim J; Som PM; Kostakoglu L
Laryngoscope; 2013 Nov; 123(11):2664-9. PubMed ID: 23553147
[TBL] [Abstract][Full Text] [Related]
24. The use of positron emission tomography scanning in occult and recurrent head and neck cancer.
Manolidis S; Donald PJ; Volk P; Pounds TR
Acta Otolaryngol Suppl; 1998; 534():1-11. PubMed ID: 9726577
[No Abstract] [Full Text] [Related]
25. Positron emission tomography in the evaluation of stage III and IV head and neck cancer.
Teknos TN; Rosenthal EL; Lee D; Taylor R; Marn CS
Head Neck; 2001 Dec; 23(12):1056-60. PubMed ID: 11774391
[TBL] [Abstract][Full Text] [Related]
26. Normal and abnormal patterns of 18F-fluorodeoxyglucose PET/CT in lymphoma.
Bar-Shalom R
Radiol Clin North Am; 2007 Jul; 45(4):677-88, vi-vii. PubMed ID: 17706532
[TBL] [Abstract][Full Text] [Related]
27. [A proposal for the rational use of the PET in oncology].
Borrego Dorado I; Vázquez Albertino R
Rev Esp Med Nucl; 2002 May; 21(3):163-73. PubMed ID: 12206749
[TBL] [Abstract][Full Text] [Related]
28. Where can FDG-PET contribute most to anatomical imaging problems?
Bingham JB
Br J Radiol; 2002 Nov; 75 Spec No():S39-52. PubMed ID: 12519735
[No Abstract] [Full Text] [Related]
29. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
30. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma.
Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372
[TBL] [Abstract][Full Text] [Related]
31. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
[TBL] [Abstract][Full Text] [Related]
32. Preoperative
Cho JK; Ow TJ; Lee AY; Smith RV; Schlecht NF; Schiff BA; Tassler AB; Lin J; Moadel RM; Valdivia A; Abraham T; Gulko E; Neimark M; Ustun B; Bello JA; Shifteh K
Otolaryngol Head Neck Surg; 2017 Sep; 157(3):439-447. PubMed ID: 28608737
[TBL] [Abstract][Full Text] [Related]
33. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans.
Eloubeidi MA; Cerfolio RJ; Chen VK; Desmond R; Syed S; Ojha B
Ann Thorac Surg; 2005 Jan; 79(1):263-8. PubMed ID: 15620955
[TBL] [Abstract][Full Text] [Related]
34. PET versus PET/CT dual-modality imaging in evaluation of lung cancer.
Freudenberg LS; Rosenbaum SJ; Beyer T; Bockisch A; Antoch G
Radiol Clin North Am; 2007 Jul; 45(4):639-44, v. PubMed ID: 17706528
[TBL] [Abstract][Full Text] [Related]
35. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer.
Hanasono MM; Kunda LD; Segall GM; Ku GH; Terris DJ
Laryngoscope; 1999 Jun; 109(6):880-5. PubMed ID: 10369275
[TBL] [Abstract][Full Text] [Related]
36. [The role of diagnostic PET in treatment planning before tumor surgery].
Haberkorn U
Chirurg; 2001 Sep; 72(9):1010-9. PubMed ID: 11594269
[TBL] [Abstract][Full Text] [Related]
37. [The value of PET-CT imaging in malignant tumours of the head and neck].
Balink H; Krabbe CA; de Visscher JG
Ned Tijdschr Geneeskd; 2007 May; 151(21):1167-72. PubMed ID: 17557755
[TBL] [Abstract][Full Text] [Related]
38. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis.
Gould MK; Kuschner WG; Rydzak CE; Maclean CC; Demas AN; Shigemitsu H; Chan JK; Owens DK
Ann Intern Med; 2003 Dec; 139(11):879-92. PubMed ID: 14644890
[TBL] [Abstract][Full Text] [Related]
39. [F-18 fluorodeoxyglucose positron emission tomography in colorectal carcinoma].
Jörg L; Langsteger W
Wien Med Wochenschr; 2002; 152(11-12):276-9. PubMed ID: 12138655
[TBL] [Abstract][Full Text] [Related]
40. A head and neck surgeon's perspective on best practices for the use of PET/CT scans for the diagnosis and treatment of head and neck cancers.
Funk GF
Arch Otolaryngol Head Neck Surg; 2012 Aug; 138(8):748-52. PubMed ID: 22911297
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
